Advanced Human Imaging Limited Sponsored ADR

AHI Technology Software Application

Advanced Human Imaging Limited Sponsored ADR’s revenue for fiscal 2023 (year ended June 2023) was $1.9 million, up 484.3% from fiscal 2022. Revenue growth for three consecutive years, operating cash flow growth for three.

1.50 0.00 0.00%
Market cap
$13.2M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
3/9
Altman Z
−13.29
Beneish M
−1.44
Dividend safety
n/a

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 68.54%

Capital & Financial Ratios $m

Market Cap 13.15
Revenue 0.58
Net Income (23.20)
Free Cash Flow (18.23)
Net Debt 2.04
Current Ratio 0.20 (below 1: weak)
Debt/Equity (1.14) (negative: negative equity)
P/E ratio 0.00
Fwd P/E 0.00
P/S ratio 44.05 (above 10: high)
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next Y revenue growth (91.46%) (below 0%: weak)
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2021 Powerpack
2020 Powerpack
2019 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2021 2022 2023 Q'23
Cash 2 4 1 0
Receivables 0 0 0 0
Inventory — — — —
Other — — — —
4 5 2 1
2021 2022 2023 Q'23
Payables 1 0 2 3
ST’ Debt 2 1 1 1
Other 1 1 0 1
3 1 4 5

Compound Annual Growth %

10y 5y 3y
Sales — 9.59% 41.21%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 21.50% 43.45%

Revenue $m

Mar Jun Sep Dec Year
’26 — — — — —
’23 — — — — 2
’22 — — — — 0
’21 — — — — 1
’20 — — — 0 1
’19 — 0 — — 0
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’23 — — — — (5)
’22 — — — — (7)
’21 — — — — (4)
’20 — — — (1) (3)
’19 — (1) — — (2)
’18 — — — — (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — (3) —
’23 — (5) — (3) (5)
’22 — (7) — (3) (7)
’21 — (4) — (1) (4)
’20 — (3) — (1) (3)
’19 — (1) — — (2)
’18 — — — — (1)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 — — — — —
’23 — — — — (1.31)
’22 — — — — (2.66)
’21 — — — — (3.14)
’20 — — — (0.02) (1.44)
’19 — (0.02) — — (0.03)
’18 — — — — (0.13)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to June

Group Line 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Trend 2024e 2025e 2026e
Price, $
Price, $ Low — — — — — — — 12.16 1.40 0.64

Analyst estimates 2024–2026

Powerpack
High — — — — — — — 31.08 20.92 15.52
People
People Employees — — — — — — — 19 19 32
Revenue/emp, $m — — — — 0.00 0.00 0.00 0.06 0.02 0.06
Income, $m
Income, $m Revenue — — — — 1 0 1 1 0 2
Gross margin, % — — — 0.00 88.39 0.00 100.00 100.00 100.00 100.00
EBT — — — (2) (11) (4) (6) (15) (15) (9)
EBT margin, % — — — 0.00 (921.85) (122,443.48) (908.68) (1,234.75) (4,731.42) (459.69)
Net income — — — 0 (10) (3) (5) (14) (15) (9)
Depreciation — — — 0 0 0 0 0 0 0
Per share, $
Per share, $ Revenue — — — 0.00 0.10 0.00 0.18 0.27 0.06 0.28
Earnings — — — (0.02) (0.13) (0.03) (1.44) (3.14) (2.66) (1.24)
Cash flow — — — (0.11) (0.08) (0.64) (0.72) (0.92) (1.30) (0.75)
Capex — — — 0.00 0.00 0.00 (0.02) (0.01) (0.01) (0.01)
Free cash flow — — — (0.11) (0.08) (0.64) (0.74) (0.92) (1.32) (0.76)
Book value — — — 0.14 0.04 0.11 0.12 0.44 1.13 0.21
Shares, m — — — 13 12 4 4 4 5 7
Valuation, ×
Valuation, × P/E — — — — 0.00 0.00 0.00 0.00 0.00 0.00
P/S — — — — 519.26 519.26 519.26 519.26 66.00 112.47
P/B — — — — 145.13 145.13 145.13 145.13 6.34 47.60
EV/Sales — — — — 519.37 519.37 519.37 519.37 60.12 112.04
EV/FCF — — — — (32.09) (32.09) (32.09) (32.09) (2.41) (3.66)
Cash, $m
Cash, $m Operating cash flow — — — (1) (1) (2) (3) (4) (7) (5)
Capex — — — (1) 0 0 0 0 0 0
Free cash flow — — — (1) (1) (2) (3) (4) (7) (5)
Balance, $m
Balance, $m Working capital — — — 1 0 (1) (1) 1 4 (2)
Total debt — — — — 0 1 1 2 1 1
Net debt — — — (1) 0 1 1 0 (4) 0
Shareholders’ equity — — — 2 1 0 0 2 6 1
Returns, %
Returns, % ROA — — — (90.94) (1,384.20) (183.02) (225.12) (335.76) (221.40) (125.76)
ROIC — — — 0.00 0.00 0.00 (318.73) (449.56) (358.47) (474.08)
ROE — — — (138.90) (850.28) (677.61) (1,275.35) (1,152.26) (355.91) (228.08)
Negative figures in brackets.

All 10 years →

Fiscal years to Jun 2023 · latest quarter Dec 2019

Charts ten years each

Advanced Human Imaging Limited Sponsored ADR vs peers in Software Application (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
YAAS Youxin Technology Ltd $16.2M — — — — −95.02% (below 0%: shrinking) — — Compare
IDAI T Stamp Inc. $15.9M — (loss-making) — (loss-making) +10.73% (above 0%: growing) n/m −205.91% (below 0%: shrinking) 53.49% (266.39%) Compare
IPM Intelligent Protection Management Corp. $15.5M — (loss-making) — (loss-making) +12.93% (above 0%: growing) n/m +42.70% (above 0%: growing) 41.33% (23.40%) Compare
RPGL Republic Power Group Limited $13.9M — — — — −1,728.88% (below 0%: shrinking) — — Compare
AHI Advanced Human Imaging Limited Sponsored ADR $13.2M — (loss-making) — (loss-making) +307.96% (above 0%: growing) n/m −21.40% (below 0%: shrinking) 0.00% 0.00%
SMSI Smith Micro Software, Inc. $12.9M — (loss-making) — (loss-making) −1.79% (below 0%: shrinking) n/m +61.05% (above 0%: growing) 81.32% (54.57%) Compare
FUSE Fusemachines Inc. $12.3M — (loss-making) — — n/m −432.02% (below 0%: shrinking) 53.68% (149.94%) Compare
PSQH PSQ Holdings, Inc. $11.4M — (loss-making) — (loss-making) +107.83% (above 0%: growing) n/m +63.26% (above 0%: growing) 57.96% (67.15%) Compare
SAGT SAGTEC GLOBAL LIMITED $10.6M — — — — +393.44% (above 0%: growing) — — Compare
Median of peers $13.4M — — +11.83% — −26.16% 53.68% (67.15%)

All 237 Software Application stocks →

Advanced Human Imaging Limited Sponsored ADR (AHI) key facts

  • Strength: Advanced Human Imaging Limited Sponsored ADR’s revenue for fiscal 2023 (year ended June 2023) was $1.9 million, up 484.3% from fiscal 2022.
  • Advanced Human Imaging Limited Sponsored ADR (AHI) is a Software Application company in the Technology sector, traded in the US as an ADR.
  • As of August 14, 2025, AHI traded at $1.50, a market capitalization of $13.2 million.
  • Return on equity was −228.1% and debt-to-equity -1.14.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is −13.29 (distress zone) for fiscal 2023.

Source: company filings (standardised) and stockrow calculations.

Advanced Human Imaging Limited Sponsored ADR (AHI) Latest News

No news at this impact. Lower the threshold for more.

stockrow.com/AHI · Data as of Dec 31, 2019 · For information only; not investment advice. · © 2026 stockrow.com